inflammation semaglutide targets MASH molecular pathways beyond weight loss GLP-1s show signs of slowing

The GPO model works because the drugs competitive market is already doing the work of price compression, and the GPO is simply capturing and passing through that market price

GLP-1 medications (not-FDA approved) are designed for long-term use and are not intended as a short-term solution

Berberine primarily affects intracellular energy metabolism and may have direct effects on glucose transporters and insulin signalling

Will be useful to all clinicians and nutritionists Screening & Diagnosis Who: Screen all adults with Type 2 #Diabetes (T2D) for #MASLD, regardless of liver enzyme levels

Front Psychiatry 15:1362288